Brain metastasis in a patient with melanoma receiving Pembrolizumab therapy: A case report and review of the literature

RATIONALE: Melanoma with brain metastasis is associated with a poor prognosis and high mortality rate. As patients with this condition have been excluded from most clinical trials, data on the use of anti–programmed death 1 therapy for these patients are limited. PATIENT CONCERNS: The patient was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Jin-cheng, Ding, Xiao-lei, Sun, Xiu-hua, Safi, Mohammed, Tian, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815794/
https://www.ncbi.nlm.nih.gov/pubmed/29390382
http://dx.doi.org/10.1097/MD.0000000000009278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815794/
https://www.ncbi.nlm.nih.gov/pubmed/29390382
http://dx.doi.org/10.1097/MD.0000000000009278

Ejemplares similares